Stephen A. Sherwin

Stephen A. Sherwin, M.D., has served on our board of directors since 2015 and is a member of the board’s Science and Technology Committee. Dr. Sherwin currently divides his time between advisory work in the life science industry and patient care and teaching in his specialty of medical oncology. He is a Clinical Professor of Medicine at the University of California, San Francisco, and a volunteer Attending Physician in Hematology-Oncology at the Zuckerberg San Francisco General Hospital. In addition to his advisory work with Aduro, Dr. Sherwin serves as a director of Biogen and Neurocrine Biosciences and as a venture partner at Third Rock Ventures. He is also a member of the scientific steering committee of the Parker Institute for Cancer Immunotherapy. Dr. Sherwin holds a B.A. in Biology from Yale University, where he graduated summa cum laude, and an M.D. from Harvard Medical School. He is board-certified in internal medicine and medical oncology and a fellow of the American College of Physicians.